Published in J Colloid Interface Sci on March 02, 2007
On the mechanism of pore formation by melittin. J Biol Chem (2008) 1.13
Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother (2008) 1.11
Boosting antimicrobial peptides by hydrophobic oligopeptide end tags. J Biol Chem (2009) 1.03
Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS One (2011) 1.02
Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS One (2009) 0.90
Lipid composition-dependent membrane fragmentation and pore-forming mechanisms of membrane disruption by pexiganan (MSI-78). Biochemistry (2013) 0.88
Comprehensive characterization of molecular interactions based on nanomechanics. PLoS One (2008) 0.88
Role of nanoparticle surface functionality in the disruption of model cell membranes. Langmuir (2012) 0.81
Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity. PLoS One (2012) 0.81
Phospholipid flip-flop modulated by transmembrane peptides WALP and melittin. J Struct Biol (2009) 0.81
Melittin-lipid bilayer interactions and the role of cholesterol. Biophys J (2008) 0.81
Multiple membrane interactions and versatile vesicle deformations elicited by melittin. Toxins (Basel) (2013) 0.80
Functional characterization of a melittin analog containing a non-natural tryptophan analog. Biopolymers (2015) 0.76
Pronounced peptide selectivity for melanoma through tryptophan end-tagging. Sci Rep (2016) 0.75
Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response. J Venom Anim Toxins Incl Trop Dis (2016) 0.75
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta (2007) 1.56
Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A (2004) 1.51
Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol (2011) 1.44
Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. Biophys J (2003) 1.43
The contact system--a novel branch of innate immunity generating antibacterial peptides. EMBO J (2006) 1.36
Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt. FEBS J (2006) 1.14
Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog (2010) 1.12
Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta (2007) 1.12
Direct observation and characterization of DMPC/DHPC aggregates under conditions relevant for biological solution NMR. Biochim Biophys Acta (2004) 1.12
Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother (2008) 1.11
End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One (2009) 1.04
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim Biophys Acta (2006) 1.04
Boosting antimicrobial peptides by hydrophobic oligopeptide end tags. J Biol Chem (2009) 1.03
C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules. J Biol Chem (2010) 1.02
The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob Agents Chemother (2008) 1.01
Formation of transition metal-doxorubicin complexes inside liposomes. Biochim Biophys Acta (2002) 1.00
Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. Bioconjug Chem (2002) 0.99
Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Am J Respir Cell Mol Biol (2011) 0.98
In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother (2006) 0.97
Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry (2008) 0.95
Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog (2008) 0.95
pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol. Biochim Biophys Acta (2004) 0.95
Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro. FEBS J (2007) 0.94
Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem (2006) 0.94
Effect of peptide length on the interaction between consensus peptides and DOPC/DOPA bilayers. Langmuir (2006) 0.94
All-or-none membrane permeabilization by fengycin-type lipopeptides from Bacillus subtilis QST713. Biochim Biophys Acta (2011) 0.94
Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. Biophys J (2006) 0.94
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. J Pharm Sci (2005) 0.92
Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. J Biol Chem (2010) 0.92
Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention. J Control Release (2005) 0.91
Recombinant spider silk as matrices for cell culture. Biomaterials (2010) 0.91
Interactions between pH-sensitive liposomes and model membranes. Biophys Chem (2003) 0.91
Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS One (2009) 0.90
Protein C inhibitor--a novel antimicrobial agent. PLoS Pathog (2009) 0.90
Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation. Pharm Res (2006) 0.90
Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes. J Control Release (2005) 0.90
An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir (2007) 0.90
Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa. Biochim Biophys Acta (2009) 0.89
Electrochemical impedance spectroscopy in label-free biosensor applications: multivariate data analysis for an objective interpretation. Anal Bioanal Chem (2010) 0.89
Structure-activity studies and therapeutic potential of host defense peptides of human thrombin. Antimicrob Agents Chemother (2011) 0.89
Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. Biochim Biophys Acta (2006) 0.88
Thymic stromal lymphopoietin exerts antimicrobial activities. Exp Dermatol (2011) 0.88
Microgels and microcapsules in peptide and protein drug delivery. Adv Drug Deliv Rev (2011) 0.88
Enzymatic degradation of model cellulose films. J Colloid Interface Sci (2005) 0.88
Morphology of magnetically aligning DMPC/DHPC aggregates-perforated sheets, not disks. Langmuir (2006) 0.88
Peptide-microgel interactions in the strong coupling regime. J Phys Chem B (2012) 0.88
Mechanism of lysozyme uptake in poly(acrylic acid) microgels. J Phys Chem B (2009) 0.88
Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis. PLoS One (2012) 0.88
Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy. J Control Release (2010) 0.87
Disc formation in cholesterol-free liposomes during phase transition. Biochim Biophys Acta (2003) 0.87
An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes. J Control Release (2004) 0.87
Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. J Control Release (2005) 0.87
Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. J Liposome Res (2008) 0.86
Membrane selectivity by W-tagging of antimicrobial peptides. Biochim Biophys Acta (2010) 0.86
Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes. Int J Pharm (2007) 0.85
Proteolytic activation transforms heparin cofactor II into a host defense molecule. J Immunol (2013) 0.85
Cyclotide-membrane interactions: defining factors of membrane binding, depletion and disruption. Biochim Biophys Acta (2011) 0.85
Melittin-lipid interaction: a comparative study using liposomes, micelles and bilayer disks. Biochim Biophys Acta (2008) 0.84
Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta (2006) 0.84
Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition. Biochim Biophys Acta (2006) 0.84
Massive formation of intracellular membrane vesicles in Escherichia coli by a monotopic membrane-bound lipid glycosyltransferase. J Biol Chem (2009) 0.83
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy. Nucl Med Biol (2006) 0.83
Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity. J Control Release (2005) 0.83
SufA of the opportunistic pathogen finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation. J Biol Chem (2009) 0.83
Unilamellar vesicles obtained by simply mixing dioctadecyldimethylammonium chloride and bromide with water. Chem Phys Lipids (2006) 0.83
Antimicrobial activity of peptides derived from human ß-amyloid precursor protein. J Pept Sci (2012) 0.83
The C-terminal sequence of several human serine proteases encodes host defense functions. J Innate Immun (2011) 0.83
Optimized protocol for on-target phosphopeptide enrichment prior to matrix-assisted laser desorption-ionization mass spectrometry using mesoporous titanium dioxide. Anal Chem (2010) 0.82
Importance of lipopolysaccharide aggregate disruption for the anti-endotoxic effects of heparin cofactor II peptides. Biochim Biophys Acta (2013) 0.82
The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis. PLoS Pathog (2013) 0.82
Visualizing the interaction between poly-L-lysine and poly(acrylic acid) microgels using microscopy techniques: effect of electrostatics and peptide size. Langmuir (2006) 0.82
Oligotryptophan-tagged antimicrobial peptides and the role of the cationic sequence. Biochim Biophys Acta (2009) 0.82
Thermoresponsive, hydrolytically degradable polymer micelles intended for radionuclide delivery. Macromol Biosci (2009) 0.81
The epithelium-produced growth factor midkine has fungicidal properties. J Antimicrob Chemother (2012) 0.81
Evaluation of bilayer disks as plant cell membrane models in partition studies. Anal Biochem (2007) 0.81
β-Microseminoprotein endows post coital seminal plasma with potent candidacidal activity by a calcium- and pH-dependent mechanism. PLoS Pathog (2012) 0.81
Nanosized bilayer disks: attractive model membranes for drug partition studies. Biochim Biophys Acta (2007) 0.81
Membrane and lipopolysaccharide interactions of C-terminal peptides from S1 peptidases. Biochim Biophys Acta (2012) 0.81
Melittin-lipid bilayer interactions and the role of cholesterol. Biophys J (2008) 0.81
Incorporation of antimicrobial compounds in mesoporous silica film monolith. Biomaterials (2009) 0.81
Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity. PLoS One (2012) 0.81
Development of non-phospholipid liposomes containing a high cholesterol concentration. Langmuir (2007) 0.81
Model cellulose films exposed to H. insolens glucoside hydrolase family 45 endo-cellulase--the effect of the carbohydrate-binding module. J Colloid Interface Sci (2005) 0.80
PEG-stabilized lipid disks as carriers for amphiphilic antimicrobial peptides. J Control Release (2011) 0.80
Extruded vesicles of dioctadecyldimethylammonium bromide and chloride investigated by light scattering and cryogenic transmission electron microscopy. J Colloid Interface Sci (2008) 0.80
Development and initial evaluation of PEG-stabilized bilayer disks as novel model membranes. Biophys Chem (2005) 0.80
Structural effects caused by spray- and freeze-drying of liposomes and bilayer disks. J Pharm Sci (2010) 0.80
Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy. Bioconjug Chem (2007) 0.79
Effect of charge density on the interaction between cationic peptides and oppositely charged microgels. J Phys Chem B (2010) 0.79
Protein-polyelectrolyte cluster formation and redissolution: a Monte Carlo study. J Am Chem Soc (2003) 0.79
Ligand liposomes and boron neutron capture therapy. J Neurooncol (2003) 0.79
Biotinylated lipid bilayer disks as model membranes for biosensor analyses. Anal Biochem (2010) 0.79
Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis. Wien Med Wochenschr (2007) 0.78